1. Home
  2. EEX vs WVE Comparison

EEX vs WVE Comparison

Compare EEX & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EEX
  • WVE
  • Stock Information
  • Founded
  • EEX 2013
  • WVE 2012
  • Country
  • EEX United States
  • WVE Singapore
  • Employees
  • EEX N/A
  • WVE N/A
  • Industry
  • EEX Advertising
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • EEX Consumer Discretionary
  • WVE Health Care
  • Exchange
  • EEX Nasdaq
  • WVE Nasdaq
  • Market Cap
  • EEX 910.8M
  • WVE 915.6M
  • IPO Year
  • EEX 2017
  • WVE 2015
  • Fundamental
  • Price
  • EEX $4.90
  • WVE $6.78
  • Analyst Decision
  • EEX Strong Buy
  • WVE Strong Buy
  • Analyst Count
  • EEX 2
  • WVE 13
  • Target Price
  • EEX $7.90
  • WVE $20.15
  • AVG Volume (30 Days)
  • EEX 116.6K
  • WVE 997.3K
  • Earning Date
  • EEX 08-06-2025
  • WVE 08-07-2025
  • Dividend Yield
  • EEX 1.22%
  • WVE N/A
  • EPS Growth
  • EEX N/A
  • WVE N/A
  • EPS
  • EEX 0.02
  • WVE N/A
  • Revenue
  • EEX $413,100,000.00
  • WVE $104,939,000.00
  • Revenue This Year
  • EEX $14.85
  • WVE N/A
  • Revenue Next Year
  • EEX $6.42
  • WVE $1.94
  • P/E Ratio
  • EEX $199.52
  • WVE N/A
  • Revenue Growth
  • EEX 4.87
  • WVE N/A
  • 52 Week Low
  • EEX $3.22
  • WVE $4.25
  • 52 Week High
  • EEX $6.74
  • WVE $16.74
  • Technical
  • Relative Strength Index (RSI)
  • EEX 59.77
  • WVE 50.88
  • Support Level
  • EEX $4.82
  • WVE $6.67
  • Resistance Level
  • EEX $4.93
  • WVE $7.18
  • Average True Range (ATR)
  • EEX 0.12
  • WVE 0.40
  • MACD
  • EEX -0.01
  • WVE 0.00
  • Stochastic Oscillator
  • EEX 65.89
  • WVE 38.83

About EEX Emerald Holding Inc.

Emerald Holding Inc is a business-to-business (B2B) event organizer principally in the United States. The company is engaged in three complementary business lines; Connections division consists of a collection of B2B trade show franchises and other live events that provide exhibitors opportunities to engage with buyers and expand their brand's awareness in their industry; the Content division consists of B2B print publications and digital media products that complement existing trade show properties, and the Commerce division which offers software-as-a-service technology that enables year-round B2B buying and selling through Elastic Suite and Bulletin platforms for use by its customers. The Majority of the revenue for the company is generated from its Connections segment.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: